Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response
Science Immunology · 20.09.2024 · 9 (99)
DOI: 10.1126/sciimmunol.adl3755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 20.09.2024. Verfasst von Sachin H Bhagchandani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Germinal Center, Immunity, Humoral. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Prolonging exposure to subunit vaccines during the primary immune response enhances humoral immunity. Escalating-dose immunization (EDI), administering vaccines every other day in an increasing pattern over 2 weeks, is particularly effective but challenging to implement clinically. Here, using an HIV Env trimer/saponin adjuvant vaccine, we explored simplified EDI regimens and found that a two-shot regimen administering 20% of the vaccine followed by the remaining 80% of the dose 7 days later increased T FH responses 6-fold, antigen-specific germinal center (GC) B cells 10-fold, and serum antibody titers 10-fold compared with bolus immunization. Computational modeling of T FH priming and the GC response suggested that enhanced activation/antigen loading on dendritic cells and increased capture of antigen delivered in the second dose by follicular dendritic cells contribute to these effects, predictions we verified experimentally. These results suggest that a two-shot priming approach can be used to substantially enhance responses to subunit vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
- Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main Street, Cambridge, MA 02139, USA.
- Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
- Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
ORCID-Profile: Sachin H Bhagchandani, Leerang Yang, Jonathan H Lam, Laura Maiorino, Elana Ben-Akiva, Kristen A Rodrigues, Anna Romanov, Heikyung Suh, Shengwei Wu, Anika Wadhera, Arup K Chakraborty, Darrell J Irvine
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- Howard Hughes Medical Institute
Zitieren
APA
Bhagchandani, S. H., Yang, L., Lam, J. H., Maiorino, L., Ben-Akiva, E., Rodrigues, K. A., Romanov, A., Suh, H., Aung, A., Wu, S., Wadhera, A., Chakraborty, A. K., & Irvine, D. J. (2024). Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response. Science Immunology, 9(99). https://doi.org/10.1126/sciimmunol.adl3755
Vancouver
Bhagchandani SH, Yang L, Lam JH, Maiorino L, Ben-Akiva E, Rodrigues KA, et al. Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response. Science Immunology. 2024;9(99). doi:10.1126/sciimmunol.adl3755
BibTeX
@article{Bhagchandani2024,
author = {Bhagchandani, Sachin H and Yang, Leerang and Lam, Jonathan H and Maiorino, Laura and Ben-Akiva, Elana and Rodrigues, Kristen A and Romanov, Anna and Suh, Heikyung and Aung, Aereas and Wu, Shengwei and Wadhera, Anika and Chakraborty, Arup K and Irvine, Darrell J},
title = {Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {99},
doi = {10.1126/sciimmunol.adl3755}
}
EUVIMED